Search

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

… Friday, December 2, 2011 Summary Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor. Pictured: Genes & Development Journal

Deb Schrag, MD, MPH, FASCO, gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), has been elected 2027-28 President of the American Society of Clinical Oncology (ASCO), the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

… Friday, December 19, 2025 Deb Schrag, MD, MPH, FASCO,   gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK),   has been elected 2027-28 President of the  American Society of Clinical Oncology (ASCO ), the world’s leading

Researchers from MSK presented findings on graft-versus-host disease and other topics at the annual meeting of bone marrow transplant and cellular therapy experts.

… Monday, February 26, 2024 Doctors and scientists from Memorial Sloan Kettering Cancer Center (MSK) presented advances in transplantation and cellular therapies at a joint meeting hosted by the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood and

… Monday, September 16, 2024 Selwyn M. Vickers, MD, FACS , the President and CEO of Memorial Sloan Cancer Center, is a renowned pancreatic cancer surgeon, health equity researcher, and hospital leader. But the title he is proudest of is ‘Dad.’  Dr. Vickers and his wife, Janice, have raised four grown children

Physician-scientist Boris C. Bastian joined Memorial Sloan Kettering as Attending Physician and Chair of the Department of Pathology on April 1.

… Thursday, July 1, 2010 Summary Physician-scientist Boris C. Bastian joined Memorial Sloan Kettering as Attending Physician and Chair of the Department of Pathology on April 1. Physician-scientist Boris C. Bastian joined Memorial Sloan Kettering as Attending Physician and Chair of the Department of Pathology

Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.

… Tuesday, August 23, 2022 Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, pain, and tingling or a “pins and needles” feeling — is a common side effect of chemotherapy treatment . Sometimes described as “chemo feet” and “chemo hands,” chemotherapy-induced peripheral neuropathy

La neuropatía periférica es un efecto secundario común de muchos tipos de quimioterapia. Obtenga información sobre qué es, por qué ocurre y cómo tratar la neuropatía periférica inducida por quimioterapia (CIPN).

… Tuesday, August 23, 2022 La neuropatía periférica , un trastorno nervioso que puede causar debilidad, entumecimiento, dolor y hormigueo o una sensación de “pinchazos”, es un efecto secundario común del tratamiento con quimioterapia . A veces descrita como “pies de quimioterapia” y “manos de quimioterapia

Hear from an MSK social worker about developing body confidence after cancer treatment.

… Wednesday, July 31, 2019 Summary A person’s body image can change during and after cancer treatment. But support is available. One MSK social worker shares common concerns and how people can find healing and hope. Even after the surgery is over, the last chemotherapy infusion has been given, and the

According to a new study published online today in the Journal of the National Cancer Institute, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.

… Tuesday, July 24, 2007 Steep Learning Curve Found According to a new study published online today in the Journal of the National Cancer Institute , prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by

In her 21 years at MSK, Tatanisha Peets has grown professionally and personally, working in Cytology, Pathology and now in Food and Nutrition services.

… Tuesday, February 22, 2022 In her 21 years at MSK,  Tatanisha Peets  has grown professionally and personally, working in Cytology, Pathology and now in Food and Nutrition services. Currently the Patient Experience Manager in Food and Nutrition Services, Tatanisha began her career at MSK as a secretary